Main navigation

IAP

IAP

InterAcademyPartnership (IAP) harnesses the expertise of the world's leading scientific minds to advance sound policies, improve public health, promote excellence in science education, and achieve other critical development goals.

Main navigation

Under the umbrella of the IAP, more than 140 national, regional and global member academies work together to support the vital role of science in seeking evidence-based solutions to the world’s most challenging problems.

As explained by Robin Fears, Director of EASAC's Biosciences Programme and Project Coordinator at IAP,

the issues raised in the recent workshop, and described in the IAP-EASAC Perspective, are vitally important for the Arctic, and to the rest of the world in consequence of changes in the Arctic. In addition, however, the priorities identified are of great general importance for all of us in tackling infectious disease, whatever its environmental origin. This global relevance has become abundantly clear in the months elapsed since the workshop: the COVID-19 pandemic has challenged us all and vastly accentuates the scope of what will continue to be needed to prepare for and respond to pathogens. In an uncertain world, we do not know specifically what will be the future infectious disease threats, but we do know that they will come. The impacts of COVID-19 on individuals, families, communities, health services and economies are all the more distressing because, in many respects, these challenges were predictable. Academy networks and others have a long history of warning about the threats. For example, the IAP’s regional academy network EASAC in 2011 brought together a series of previous assessments to warn that “assumptions that most infectious disease had been conquered are now seen to have been misplaced”...”the public health problems are urgent”… “we continue to urge new models of collaboration, accompanied by new efforts to communicate about the issues to society-at-large.

Many of the specific recommendations made previously by EASAC and others are similar to the messages emerging recently from the Arctic workshop discussions: for example, developing improved surveillance and early warning systems; engagement with local communities; investment in fundamental science to understand environmental triggers and the biology of novel viruses; taking the One Health/Planetary Health perspective in reporting and response mechanisms; integrating national, regional and global collaboration for public health and economy objectives. While these challenges may seem to be relatively unchanging during the past two decades, and the recommendations rather generic, what is changing are the additional opportunities to act, brought within reach by the rapid pace of scientific advance. Thus, we now have the wherewithal to expand syndromic and other surveillance, develop rapid testing, and accelerate innovation – but, hitherto, the commitment to do so has not been a political priority. Do we now have the political will to invest in appropriate levels of public health preparedness, at an appropriate level of regional and global coordination?

One other consistent message, that is at the core of IAP’s goals, is the responsibility of the scientific community to advise policy-makers and other opinion leaders on the importance of using robust scientific evidence to inform policy options. This is not enough. The scientific community has long been aware that scientific collaboration is essential, we need to do more to explain that coordination in policy-making between sectors and countries is equally important. We must redouble our efforts to urge decision-makers to act on public health in a spirit of global solidarity and in pursuit of equity and sustainability (as highlighed by the IAP Communiqué on COVID-19).